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Split hand-split food malformation (SHFM) is a congenital defect of limb development that involves the central rays
of the autopod and presents with median clefts of the hands and feet. It often includes syndactyly and aplasia/
hypoplasia of the phalanges. SHFM is a genetic condition with high genetic heterogeneity, with at least 6 associated
chromosomal loci. A locus in chromosomal region 7q21.3, associated with SHFM is referred to as SHFM1. Genes
considered to be associated with SHFM1 are DLX5 and DLX6. These two genes participate in the Wnt pathway
that has a role in limb development. The gene DYNC1I1, located proximally (centromeric) to the SHFM1 locus was
recently reported to include enhancer sequences involved in limb development in its exons 15 and 17. These
sequences were shown to cis-regulate the function of the adjacent SHFM associated genes. We report a family, in
which the father and three of his sons carry an approximately 1 Mb deletion in this chromosomal region, arr
[hg19]7q21.3(94,769,383-95,801,045)x1. The deleted region is located proximally (centromerically) adjacent to the
SHFM region at 7q21.3. It does not include the SHFM candidate genes DLX5 and DLX6, but includes the enhancer
sequences within DYNC111 and six other genes centromeric to DYNC1I1. All deletion carriers have various degrees
of intellectual disability while two of them have SHFM. This family is the eighth reported family where a chromosome
7q21.3 deletion co-segregating with SHFM involves the enhancer regions within gene DYNC111, but does not involve
the genes DLX5 and DLX 6. This is also the third family where decreased penetrance of enhancer-associated SHFM is
demonstrated. Intellectual disability was not observed in the previously reported families and may be associated with
deficiency of one or more of the 6 genes included in the reported deletion centromeric to DYNC1I1.
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Split hand-split foot malformation (SHFM), also referred
to as ectrodactyly, is a group of genetic conditions affect-
ing the limb formation. Limb defects associated with
SHFM involve the central autopod and manifest as mid-
line clefts of hands and/or feet. Six loci associated with
SHFM were described to-date. Type 1 SHFM1 is asso-
ciated with defects in chromosomal region 7q21.3 [1].
Deletions, duplications and complex chromosomal re-
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were reported in individuals with SHFM1 [2–6]. Re-
cently two enhancer sequences expressed in regions of
limb development in mouse embryos were identified
within the exons 15 and 17 of the gene DYNC1I1 that
maps centromeric to DLX5/6. These enhancer sequences
were shown to regulate the expression of DLX5/6 and
thus have a role in embryonic limb development [7, 8].
Seven families with isolated or familial SHFM, who have
deletions involving these enhancers but not the genes
DLX5/6 were reported to-date [9–12]. In two of these re-
ports decreased penetrance of these chromosomal aberra-
tions was demonstrated [9, 12]. In one of these reports
Rattanasopha et al. also showed maternal imprinting ofAccess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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additional family where four relatives carry a 7q21.3 dele-
tion involving DYNC1I1 and 6 other proximally located
genes. The carriers of this deletion have SHFM with re-
duced penetrance and intellectual disability.
Case presentation
The proband, individual II-2 on Fig. 1, was first evalu-
ated at age 9 years. He was born premature at 34 weeks
gestation with C-section because of breech presentation.
His birth weight was 4 lbs 8 oz. He stayed in the nursery
for one week due to his prematurity. At birth he was
noted to have bilateral split foot, but his hands were
unaffected. This boy had normal early development. At
school he was noted to have significant academic diffi-
culties and repeated first and second grade. He now at-
tends special education class. On conversation he had
fluent speech. He was toilet trained. On physical exam
all his growth parameters were at the 50th percentile for
age. He did not have dysmorphic features. Both his feet
had prominent midline defects (split foot) and severe
syndactyly. His Cardiology exam and ECHO exam were
normal. On his last psychology evaluation at age 11 years
his overall functioning was determined to be at 6 years
level. His score on ‘Children’s Global Assessment Scale”
(CGAS) [13] was 55 in 1–100 scale, which is in the range
described as: “Variable functioning with sporadic diffi-
culties or symptoms in several but not all social areas”.
He was unable to count after 11, was unable to name
weekdays one after another and was unable to name some
colors. He also had aggressive behavior while interacting
with his classmates. In addition to his intellectual disability
he was concluded to have adjustment disorder.
Oligo SNP array, Affimetrix Cytoscan HD (Quest
Diagnostic, San Juan CA) identified an approximately
1 Mb deletion in chromosomal region 7q21.3. The re-
ported coordinates of this abnormality were arr[hg19]
7q21.3 (94,769,383-95,801,045). The chromosomal dele-
tion included the genes PPP1R9A, PON1, PON3, PON2,
ASB4, PDK4, DYNC1I1 and SLC25A13. All siblings andFig. 1 Pedigree of the reported familyboth parents were studied using the same technology. The
proband's brother, individual II-1, was first evaluated by us
at age 13 years. This patient had uncomplicated perinatal
period. He did not have split hand/foot, but his nails were
mildly hypoplastic. He had significant speech delay. Re-
portedly he was unable to make sentences until he was
3 years old. He had academic difficulties in school and
now attends a special education class. On his latest
psychology evaluation at age 15 he had a CGAS score
of 55 similarly to his younger brother. He was also found
to have a mood disorder with periods of depression. His
ECHO exam was normal.
The proband’s second brother, individual II-3 was first
evaluated at age 3 months. He was born after pregnancy
complicated with gestational diabetes. He was born at
full term. His birth weight was 8 lbs 3 oz. At birth he was
noted to have split-hand malformation in both hands, but
not on his feet (see Fig. 2). He had midline defects and se-
vere finger syndactyly. His feet were unaffected except for
unusual position of his toe nails that appeared detached of
their beds and pointing upwards. This sibling's develop-
ment was normal during his first year of life. He was noted
to have developmental delay mainly affecting his speech at
about 20 months of age. Audiology screening was normal.
He was found to have ankyloglossia and had frenulectomy
at 20 months. His ECHO exam was normal.
These three male siblings and their father were posi-
tive for the 7q21.3 deletion (see Fig. 1). The father did not
have ectrodactyly and reportedly had mild learning dis-
ability while in school.
Conclusions
Our family and seven previously reported families [9–12]
constitute a distinct subtype of SHFM1 where the
chromosomal abnormality do not include the traditionally
SHFM- associated genes DLX5/6, but rather involve the
associated cis-enhancer sequences within the adjacent gene
DYNC111. (Fig. 3). We refer to this subgroup as eSHFM1
(enhancer type I). This enhancer type SHFM shows de-
creased penetrance regarding the limb defects as it is seen
Fig. 2 Bilateral split hand malformation observed in individual II-3
Delgado and Velinov Molecular Cytogenetics  (2015) 8:37 Page 3 of 4in our family and in two of the previously reported fam-
ilies [9, 12]. All affected individuals in our family had
inherited their deletion form their father which is in ac-
cordance with the findings of Rattanasopha et al. regarding
maternal imprinting [12]. Among the previously reported
larger families with enhancer deletions only one affected
individual had inherited his deletion from his unaffected
mother [9]. This individual’s phenotype cannot be ex-
plained with maternal imprinting and additional studies
may be needed in this family in order to address this
discrepancy. The overall penetrance of limb deformity
in such enhancer deletions considering all reported cases
with known inheritance is around 40 %. At this time the
molecular basis of the observed reduced penetrance is
unknown. The maternal imprinting of DLX5/6 shown
by Rattanashopha et al. cannot explain this reducedFig. 3 The SHFM1 chromosomal region is shown. The previously reported
DYNC1I1 are indicated with vertical red lines. The sequence hs1642 is ind
in parenthesespenetrance because some of the unaffected individuals,
including in our family, had inherited the 7q21.3 dele-
tions from their fathers. Due to the reported maternal
imprinting of DLX5/6 the inheritance of enhancer dele-
tion from one’s mother may be associated with lower
risk for SHFM. Our family did not have hearing deficit
as it was observed in some of the other reported fam-
ilies with eSHFM1. It seems that hearing deficit due to
SHFM1 related chromosomal deletions is associated with
involvement of a more telomerically (distally) located se-
quence in this area. The previously reported families
with hearing loss have deletions that include the brain
enhancer element hs 1642 [10] that is located within gene
SLC25A13. Our family corroborates the suggestion of
Taybi et al. [10] that deletion of hs1642 is associated with
hearing loss since the affected members in our family dodeletions are shown in blue. The enhancer sequences in gene
icated with vertical black line. References for the reports are shown
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involved in their deletion (Fig. 3). The apparently mild
intellectual disability observed in our family is not present
in the other reported families and seem to be associated
with hemozygocity for a gene located proximally to
DYNC111 (Fig. 3). One strong candidate gene for such
manifestations is the gene PPP1R9A. This gene was
shown to be expressed in the brain and to participate
in neuronal development [14].
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